FerMed
ActiveSummary
FerMed has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €224,070 and a net result of €54,739. Equity is growing by about 42% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Weakest financial yearnet €54,739 ▼38.2%
Net result drops to €54,739, the lowest in the series.
31-12
Financial
Equity above €200,000equity €224,070 ▲32.3%
A profit in every financial year since 2023 builds equity to €224,070.
24-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2023 to 2025net €88,553 ▲14.6%
Operating result €126,054, net result €88,553, both a record.
31-12
Financial
Equity above €150,000equity €169,331 ▲110%
A profit in every financial year since 2023 builds equity to €169,331.
29-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 29 days late
2022
10-11
Gazette deed
IncorporationAppointment: FERREIRA DE CASTRO MOUTINHO José Tomé (director) · Founder · Capital6 facts ▸
Gazette deed
Incorporation
Appointment: FERREIRA DE CASTRO MOUTINHO José Tomé (director) · Founder · Capital6 facts ▸
- Incorporation, 07-11-2022
- Founder, FERREIRA DE CASTRO MOUTINHO José Tomé
- Capital
- Director appointment, FERREIRA DE CASTRO MOUTINHO José Tomé (director (not named in the articles))
- Founding capital, €3,500
- Pre-incorporation commitments, “takeover, tous engagements pour compte société en formation” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read